Terug
40
51
Dagbereik
€ 4,22
€ 4,32
52-Weeksbereik
€ 4,08
€ 8,12
Volume
763.270
50D / 200D Gem.
€ 5,07
/
€ 6,41
Vorige Slotkoers
€ 4,12
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 13,0 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | 21,6 | 3,7 |
| Net Margin % | 11,6 | 3,8 |
| Rev Growth 5Y % | 14,7 | 10,0 |
| D/E | 0,1 | 0,2 |
Belangrijkste Punten
Revenue grew 14,68% annually over 5 years — strong growth
ROE of 21,61% indicates high profitability
Debt/Equity of 0,09 — conservative balance sheet
Generating 72,97M in free cash flow
P/E of 12,97 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,31%
Groei
Revenue Growth (5Y)
14,68%
Revenue (1Y)19,99%
Earnings (1Y)14,52%
FCF Growth (3Y)71,57%
Kwaliteit
Return on Equity
21,61%
ROIC17,17%
Net Margin11,60%
Op. Margin15,26%
Veiligheid
Debt / Equity
0,09
Current Ratio4,32
Interest Coverage35,83
Waardering
P/E Ratio
12,97
P/B Ratio2,46
EV/EBITDA7,61
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19,99% | Revenue Growth (3Y) | 14,11% |
| Earnings Growth (1Y) | 14,52% | Earnings Growth (3Y) | -15,13% |
| Revenue Growth (5Y) | 14,68% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 418,63M | Net Income (TTM) | 48,58M |
| ROE | 21,61% | ROA | 14,18% |
| Gross Margin | 82,56% | Operating Margin | 15,26% |
| Net Margin | 11,60% | Free Cash Flow (TTM) | 72,97M |
| ROIC | 17,17% | FCF Growth (3Y) | 71,57% |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 4,32 |
| Interest Coverage | 35,83 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 12,97 | P/B Ratio | 2,46 |
| P/S Ratio | 1,50 | PEG Ratio | 1,49 |
| EV/EBITDA | 7,61 | Dividend Yield | 0,00% |
| Market Cap | 629,92M | Enterprise Value | 486,33M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 418,63M | 348,88M | 321,48M | 267,84M | 242,02M |
| Net Income | 48,58M | 42,42M | 67,44M | -30,20M | -12,30M |
| EPS (Diluted) | 0,32 | 0,28 | 0,38 | -0,27 | -0,09 |
| Gross Profit | 345,62M | 288,81M | 266,84M | 219,53M | 202,39M |
| Operating Income | 63,89M | 58,87M | 37,12M | -14,73M | -7,05M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 342,65M | 263,92M | 239,05M | 171,43M | 187,93M |
| Total Liabilities | 86,11M | 70,81M | 96,33M | 96,92M | 95,35M |
| Shareholders' Equity | 256,55M | 193,11M | 142,72M | 74,51M | 92,58M |
| Total Debt | 22,53M | 24,84M | 48,10M | 52,47M | 53,29M |
| Cash & Equivalents | 166,12M | 104,42M | 82,00M | 65,95M | 87,08M |
| Current Assets | 277,47M | 191,89M | 164,26M | 134,20M | 148,52M |
| Current Liabilities | 64,27M | 45,60M | 46,01M | 43,56M | 42,36M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#610 of 1024
#46 of 195
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Value Investing (Warren Buffett)
Mar 24, 2026